Volume Support/Assist Control Mode Ventilation and Diaphragmatic Atrophy
A Phase III Randomized Trial Comparing the Effects of Volume Support and Assist Control Mode Ventilation on Ventilator-Free Days and Diaphragmatic Atrophy
University of Chicago
468 participants
Mar 4, 2019
INTERVENTIONAL
Conditions
Summary
The objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.
Eligibility
Inclusion Criteria1
- subjects > 18 years of age that have been intubated and mechanically ventilated for < 36 hours at the time of screening will be eligible for enrollment
Exclusion Criteria9
- pregnancy
- cardiopulmonary arrest
- history of diaphragmatic paralysis or neuromuscular disease
- chronic obstructive pulmonary disease (COPD) or asthma exacerbation with evidence of auto-PEEPing requiring intubation
- neuromuscular blockade
- expectation to be liberated from ventilator in < 24 hours
- history of mechanical ventilation in the last 6 months
- presence of tracheostomy
- high cervical spine injury
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This is a spontaneous mode of mechanical ventilation that depends on the patient's efforts. A target volume (6 cc/kg of IBW), PEEP and FiO2 are set by the medical team, and the ventilator varies the inspiratory pressure support with each breath to achieve the target volume. The respiratory rate is fully dependent on the patient. Sedation while on mechanical ventilation will be set at a goal RASS of 0 to -2.
This is a controlled mode of mechanical ventilation that is independent of patient's efforts. A tidal volume (6 cc/kg of IBW), respiratory rate, PEEP and FiO2 are set by the medical team. Sedation while on mechanical ventilation will be set at a goal RASS of 0 to -2.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03901924